97021067 - SUZHOU FUSE BIOSCIENCES

Information

• Trademark
• 97021067

• Source

• Serial Number

  97021067

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 10, 2021
  3 years ago

• Transaction Date

  December 13, 2023
  a year ago

• Status Date

  January 10, 2023
  2 years ago

• Location Date

  January 10, 2023
  2 years ago

• Status Code

  602

• Current Location

  TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  MMEJE, OBIEZE GINIKANW

• Attorney Docket Number

  41914-00070

  Attorney Name

  Mark A. Jansen

  Law Office Assigned Location Code

  N40

• Owners

  • Suzhou Fuse Biosciences Limited

Case File Statements

• GS0051: Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; preparations and substances for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of locoregionally active cytokines for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of oncology for medical purposes
• GS0421: Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the field of immunocytokines; providing medical and scientific research information field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Case File Event Statements

• 12/13/2023 - a year ago

  13 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/13/2023 - a year ago

  12 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 12/13/2023 - a year ago

  11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/13/2023 - a year ago

  10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 1/10/2023 - 2 years ago

  9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 1/10/2023 - 2 years ago

  8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 1/10/2023 - 2 years ago

  7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 6/27/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 6/27/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/27/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/15/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 10/19/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/14/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP